More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...
On The Readout LOUD this week, STAT reporters discuss the FDA's staff cuts, how next-gen drugs may lead to too much weight ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
Yeezy isn’t the only company being called out for its “bait-and-switch” Super Bowl commercial, a Californian company called ...
Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.
2don MSN
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...
UnitedHealth Group is under investigation by the Justice Department **over its Medicare billing prac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results